20930862

Source:http://linkedlifedata.com/resource/pubmed/id/20930862

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0205265, umls-concept:C0376358, umls-concept:C0392756, umls-concept:C1274040, umls-concept:C1555582
pubmed:issue	10
pubmed:dateCreated	2010-10-8
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101500082
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/5-alpha Reductase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Azasteroids, http://linkedlifedata.com/resource/pubmed/chemical/dutasteride
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1759-4820
pubmed:author	pubmed-author:GannPeter HPH
pubmed:issnType	Electronic
pubmed:volume	7
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	535-7
pubmed:meshHeading	pubmed-meshheading:20930862-5-alpha Reductase Inhibitors, pubmed-meshheading:20930862-Azasteroids, pubmed-meshheading:20930862-Clinical Trials, Phase III as Topic, pubmed-meshheading:20930862-Humans, pubmed-meshheading:20930862-Male, pubmed-meshheading:20930862-Prostatic Neoplasms, pubmed-meshheading:20930862-Randomized Controlled Trials as Topic, pubmed-meshheading:20930862-Treatment Outcome
pubmed:year	2010
pubmed:articleTitle	Prostate cancer: A closer look at the initial results from the REDUCE trial.
pubmed:publicationType	News